Meet Ellis, your AI planning consultant.
Send Ellis your project. He'll handle the policy, the drawings, the documents and the people — and keep your application moving until it's approved.
Extensions, conversions, HMOs, new builds and small residential developments.
Reviewing your drawings against Hackney Local Plan LP3 and the Householder Alterations SPD…
- 1Site & policy reviewComplete
- 2Drawings annotatedComplete
- 3Planning statementIn progress
- 4Pre-app submissionUp next
- 5Validation & determinationPending
Trusted by architects, builders and developers across the UK





One assistant
Everything you need to land a residential approval — all in one place.
Ellis is the system of record for your project. Policy, drawings, documents and the people involved — all working together from day one.
Use cases
Built for every kind of residential project.
Extensions
Single and double-storey rear, side and wrap-around extensions.
Loft Conversions
Dormers, hip-to-gable and mansards across permitted development & full apps.
HMOs
Sui generis, C4 and licensing-aware HMO applications.
Change of Use
Office-to-residential, retail-to-resi and ancillary use changes.
New-Build Homes
Infill plots, garden sites and small residential schemes.
Appeals
Refusal reviews, statement of case prep and appeal route advice.
Built for
One assistant, every side of the table.
Homeowners
Understand what's possible on your property before spending on architects.
Architects
Speed up policy review and free your team to focus on design.
Builders
De-risk the planning route on every project you quote.
Developers
Run feasibility on a site in minutes, not weeks.
Planning Teams
Standardise statements and validation across your portfolio.
Ask Ellis about your next residential project.
Tell Ellis what you're trying to build and he'll come back with what's possible, what's risky and what to do next.
Built for UK residential planning.
FAQ
Questions, answered.
Ellis handles the bulk of policy review, document prep and coordination. Complex or contentious applications may still need specialist human review.